	Capitaux Propres Et Réserves		Date
3M	USD 4.75B	119M	2025-12
Abbott	USD 50.83B	0	2025-09
AngioDynamics	USD 185.87M	898K	2025-02
Anika Therapeutics	USD 146.8M	867K	2025-09
AtriCure	USD 491.94M	15.43M	2025-12
Baxter International	USD 6.13B	1.11B	2025-12
Becton, Dickinson and Co.	USD 25.28B	108M	2025-12
Boston Scientific	USD 24.23B	1.58B	2025-12
Cooper Companies	USD 8.35B	64.9M	2025-06
Dexcom	USD 2.75B	19.9M	2025-12
Edwards Lifesciences	USD 10.2B	340.3M	2025-09
Globus Medical	USD 4.4B	103.14M	2025-09
Haemonetics	USD 911.45M	62.28M	2025-12
Hologic	USD 5.25B	197.2M	2025-12
ICU Medical	USD 2.13B	11.47M	2025-09
Insulet	USD 1.52B	131.1M	2025-12
Integra LifeSciences	USD 1.04B	1.09M	2025-09
J&J	USD 78.47B	0	2025-09
Medtronic	USD 48.86B	964M	2025-09
Merit Medical Systems	USD 1.53B	41.36M	2025-09
Olympus	JPY 773.35B	39.77B	2025-12
Pfizer	USD 92.8B	4.11B	2025-09
STAAR Surgical	USD 353.78M	17.21M	2025-09
Stryker	USD 21.78B	594M	2025-09
Surmodics	USD 118.9M	753K	2024-09
Tandem Diabetes Care	USD 132.96M	318K	2025-09
Teleflex	USD 3.82B	421M	2025-09
Terumo	JPY 1.52T	84.79B	2025-12
Zimmer Biomet Holdings	USD 12.77B	231.7M	2025-09

Merit Medical Systems Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.